Mark Lunt (M Lunt)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 15

Top Venues

Pharmacoepidemiology and drug safety

Rheumatology (Oxford, England)

Journal of the European Academy of Dermatology and Venereology : JEADV

Arthritis care & research

University of Manchester

Open University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Manchester

United Kingdom

Reader in Medical Statistics :: Centre for Musculoskeletal Research

Education History

Open University

United Kingdom

PHD :: Statistics

London School of Hygiene and Tropical Medicine

United Kingdom

MSC :: Medical Statistics

University of Warwick

United Kingdom

BSC :: Maths

Publications

Meghna Jani, Belay Birlie Yimer, David A Selby, Mark Lunt, Goran Nenadic, William Gregory Dixon
"Take up to eight tablets per day": Incorporating free-text medication instructions into a transparent and reproducible process for preparing drug exposure data for pharmacoepidemiology. Pharmacoepidemiology and drug safety (2023)
John McBeth, William Gregory Dixon, Susan Mary Moore, Bruce Hellman, Ben James, Simon David Kyle, Mark Lunt, Lis Cordingley, Belay Birlie Yimer, Katie L Druce
Sleep Disturbance and Quality of Life in Rheumatoid Arthritis: Prospective mHealth Study. Journal of medical Internet research 24 (4) (2022)
James Martin Gwinnutt, Katherine Jones, Kimmie L Hyrich, Mark Lunt, Bernard G Combe, Nathalie Rincheval, Adeline Ruyssen-Witrand, Bruno Fautrel, Daniel Frederick McWilliams, David A Walsh, Elena Nikiphorou, Patrick D W Kiely, Adam Young, Jacqueline R Chipping, Alexander J MacGregor, Suzanne M M Verstappen
Exploring the disparity between inflammation and disability in the 10-year outcomes of people with rheumatoid arthritis. Rheumatology (Oxford, England) 61 (12) (2022)
James Martin Gwinnutt, Katherine Jones, Kimmie L Hyrich, Mark Lunt, Bernard Combe, Nathalie Rincheval, Adeline Ruyssen-Witrand, Bruno Fautrel, Daniel Frederick McWilliams, David A Walsh, Elena Nikiphorou, Patrick D W Kiely, Adam Young, Jacqueline R Chipping, Alex MacGregor, Suzanne M M Verstappen
Influence of Social Support, Financial Status, and Lifestyle on the Disparity Between Inflammation and Disability in Rheumatoid Arthritis. Arthritis care & research (2022)
James Martin Gwinnutt, Katherine Jones, Kimmie L Hyrich, Mark Lunt, Bernard Combe, Nathalie Rincheval, Adeline Ruyssen-Witrand, Bruno Fautrel, Daniel Frederick McWilliams, David A Walsh, Elena Nikiphorou, Patrick D W Kiely, Adam Young, Jacqueline R Chipping, Alex MacGregor, Suzanne M M Verstappen
Influence of Social Support, Financial Status, and Lifestyle on the Disparity Between Inflammation and Disability in Rheumatoid Arthritis. Arthritis care & research (2022)
Belay Birlie Yimer, David M Schultz, Anna L Beukenhorst, Mark Lunt, Huai Leng Pisaniello, Thomas House, Jamie C Sergeant, John McBeth, William Gregory Dixon
Heterogeneity in the association between weather and pain severity among patients with chronic pain: a Bayesian multilevel regression analysis. Pain reports 7 (1) (2022)
Kayleigh J Mason, A David Burden, Jonathan N W N Barker, Mark Lunt, H Ali, C Elise Kleyn, K McElhone, Moetaza Soliman, Adéle C Green, Christopher Ernest Maitland Griffiths, Nick J Reynolds, A D Ormerod, null null
Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non-biologic systemic therapies. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (8) (2021)
Kayleigh J Mason, A David Burden, Jonathan N W N Barker, Mark Lunt, H Ali, C Elise Kleyn, K McElhone, Moetaza Soliman, Adéle C Green, Christopher Ernest Maitland Griffiths, Nick J Reynolds, A D Ormerod, null null
Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (8) (2021)
James Martin Gwinnutt, Husain Alsafar, Kimmie L Hyrich, Mark Lunt, Richard B Warren, Suzanne M M Verstappen, null null
Do people with rheumatoid arthritis maintain their physical activity level at treatment onset over the first year of methotrexate therapy? Rheumatology (Oxford, England) 60 (10) (2021)
Meghna Jani, Belay Birlie Yimer, Therese Sheppard, Mark Lunt, William G Dixon
Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: A retrospective cohort study. PLoS medicine 17 (10) (2020)
Michael J Cook, Antony K Sorial, Mark Lunt, Tim N Board, Terence W O'Neill
Effect of Timing and Duration of Statin Exposure on Risk of Hip or Knee Revision Arthroplasty: A Population-based Cohort Study. The Journal of rheumatology 47 (3) (2019)
William Gregory Dixon, Anna L Beukenhorst, Belay B Yimer, Louise Cook, Antonio Gasparrini, Tal El-Hay, Bruce Hellman, Ben James, Ana M Vicedo-Cabrera, Malcolm Maclure, Ricardo Silva, John Anisworth, Huai Leng Pisaniello, Thomas A House, Mark Lunt, Carolyn Gamble, Caroline Sanders, David M Schultz, Jamie C Sergeant, John McBeth
How the weather affects the pain of citizen scientists using a smartphone app. NPJ digital medicine 2 (2019)
Emily Granger, Jamie C Sergeant, Mark Lunt
Avoiding pitfalls when combining multiple imputation and propensity scores. Statistics in medicine 38 (26) (2019)
Rebecca M Joseph, Tjeerd Pieter van Staa, Mark Lunt, Michal Abrahamowicz, William Gregory Dixon
Exposure measurement error when assessing current glucocorticoid use using UK primary care electronic prescription data. Pharmacoepidemiology and drug safety 28 (2) (2018)
Stephen R Pye, Thérèse Sheppard, Rebecca M Joseph, Mark Lunt, Nadyne Girard, Jennifer S Haas, David W Bates, David L Buckeridge, Tjeerd Pieter van Staa, Robyn Tamblyn, William Gregory Dixon
Assumptions made when preparing drug exposure data for analysis have an impact on results: An unreported step in pharmacoepidemiology studies. Pharmacoepidemiology and drug safety 27 (7) (2018)

Mark Lunt.css-eqlu8i{font-size:small;padding-left:4px;} (M Lunt)

Publication Activity (10 Years)

Top Topics

Top Venues

Mark Lunt (M Lunt)